330 related articles for article (PubMed ID: 30962862)
1. FOXO1 Overexpression Attenuates Tubulointerstitial Fibrosis and Apoptosis in Diabetic Kidneys by Ameliorating Oxidative Injury via TXNIP-TRX.
Ji L; Wang Q; Huang F; An T; Guo F; Zhao Y; Liu Y; He Y; Song Y; Qin G
Oxid Med Cell Longev; 2019; 2019():3286928. PubMed ID: 30962862
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis.
Han Y; Xu X; Tang C; Gao P; Chen X; Xiong X; Yang M; Yang S; Zhu X; Yuan S; Liu F; Xiao L; Kanwar YS; Sun L
Redox Biol; 2018 Jun; 16():32-46. PubMed ID: 29475133
[TBL] [Abstract][Full Text] [Related]
3. FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.
Huang F; Wang Q; Guo F; Zhao Y; Ji L; An T; Song Y; Liu Y; He Y; Qin G
EBioMedicine; 2019 Oct; 48():491-504. PubMed ID: 31629675
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
5. ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy.
Chen N; Song S; Yang Z; Wu M; Mu L; Zhou T; Shi Y
J Diabetes Complications; 2021 Dec; 35(12):108050. PubMed ID: 34600826
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux.
Huang C; Lin MZ; Cheng D; Braet F; Pollock CA; Chen XM
Lab Invest; 2014 Mar; 94(3):309-20. PubMed ID: 24492284
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells.
Shah A; Xia L; Goldberg H; Lee KW; Quaggin SE; Fantus IG
J Biol Chem; 2013 Mar; 288(10):6835-48. PubMed ID: 23329835
[TBL] [Abstract][Full Text] [Related]
10. Effects of overexpressing FoxO1 on apoptosis in glomeruli of diabetic mice and in podocytes cultured in high glucose medium.
Li W; Wang Q; Du M; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
Biochem Biophys Res Commun; 2016 Sep; 478(2):612-7. PubMed ID: 27475499
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy.
Tan CY; Weier Q; Zhang Y; Cox AJ; Kelly DJ; Langham RG
Nephron; 2015; 129(2):109-27. PubMed ID: 25662516
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box A2-mediated lncRNA SOX2OT up-regulation alleviates oxidative stress and apoptosis of renal tubular epithelial cells by promoting SIRT1 expression in diabetic nephropathy.
Ye G; Hu ML; Xiao L
Nephrology (Carlton); 2023 Mar; 28(3):196-207. PubMed ID: 36576135
[TBL] [Abstract][Full Text] [Related]
13. TXNIP deficiency attenuates renal fibrosis by modulating mTORC1/TFEB-mediated autophagy in diabetic kidney disease.
Du Y; Wu M; Song S; Bian Y; Shi Y
Ren Fail; 2024 Dec; 46(1):2338933. PubMed ID: 38616177
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of telmisartan in Type 2 diabetes rat kidneys is related to the downregulation of thioredoxin-interacting protein.
Wu J; Lin H; Liu D; Liu J; Wang N; Mei X; Sun J; Yang G; Zhang X
J Endocrinol Invest; 2013; 36(7):453-9. PubMed ID: 23211392
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer.
Li W; Wu Z; Ma Q; Liu J; Xu Q; Han L; Duan W; Lv Y; Wang F; Reindl KM; Wu E
Curr Cancer Drug Targets; 2014; 14(4):348-56. PubMed ID: 24720336
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin IV attenuates diabetic cardiomyopathy
Zhang M; Sui W; Xing Y; Cheng J; Cheng C; Xue F; Zhang J; Wang X; Zhang C; Hao P; Zhang Y
Theranostics; 2021; 11(18):8624-8639. PubMed ID: 34522203
[No Abstract] [Full Text] [Related]
17. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression.
Zhang X; Zhao S; Yuan Q; Zhu L; Li F; Wang H; Kong D; Hao J
Cell Death Dis; 2021 Jun; 12(7):642. PubMed ID: 34162834
[TBL] [Abstract][Full Text] [Related]
18. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
[TBL] [Abstract][Full Text] [Related]
19. Effect of forkhead box O1 in renal tubular epithelial cells on endotoxin-induced acute kidney injury.
Zhang M; Dong W; Li Z; Xiao Z; Xie Z; Ye Z; Liu S; Li R; Chen Y; Zhang L; Wang M; Liang H; Baihetiyaer R; Apaer R; Dong Z; Liang X
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F262-F272. PubMed ID: 33356954
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells.
Li X; Rong Y; Zhang M; Wang XL; LeMaire SA; Coselli JS; Zhang Y; Shen YH
Biochem Biophys Res Commun; 2009 Apr; 381(4):660-5. PubMed ID: 19254690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
